Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
Jan 30 (Reuters) - Dr. Lal Path Labs (DLPA.NS), opens new tab reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand ...
Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, bundled test ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the ...
July 24 (Reuters) - Indian diagnostics firm Dr Lal PathLabs on Friday reported a rise in first-quarter profit, boosted by sustained demand for its tests and preventive health packages under the ...
Shares of Dr Lal Path Labs surged in morning trade on Monday after the diagnostics company reported better-than-expected June quarter results. The stock climbed as much as 7.55 percent during the ...
Hosted on MSN
Imane Khelif’s chromosome test from Dr Lal Path Labs leaked amid gender row. What it shows
Algerian boxer Imane Khelif, who won gold at the Paris Olympics last summer, is once again at the centre of controversy over her biological sex. Khelif won gold at the Paris Games last summer - but it ...
Trade Brains on MSN
Dr Lal PathLabs to acquire 70% stake in Gujarat-based SN Genelab for up to Rs199.5 cr
India, Sept. 25 -- This company belongs to the group of diagnostic services companies in India offering pathology, clinical laboratory, and diagnostic test services through their laboratories and ...
Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...
Consolidated net profit for the three months ended June 30 rose to 1.70 billion rupees ($17.62 million) from 1.32 billion rupees a year earlier. Consolidated net profit for the three months ended ...
Diagnostics firm Dr Lal PathLabs on Friday reported a rise in first-quarter profit, boosted by sustained demand for its tests and preventive health packages under the SwasthFit banner. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results